Latest Insider Transactions at Crispr Therapeutics Ag (CRSP)
This section provides a real-time view of insider transactions for Crispr Therapeutics Ag (CRSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CRISPR Therapeutics AG to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CRISPR Therapeutics AG's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 17
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,895
-16.68%
|
$3,409,965
$67.91 P/Share
|
|
Oct 16
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+24.69%
|
-
|
|
Oct 14
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,076
-1.27%
|
$71,016
$66.6 P/Share
|
|
Oct 14
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,242
-2.03%
|
$279,972
$66.6 P/Share
|
|
Oct 13
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,114
+2.44%
|
-
|
|
Oct 13
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+3.83%
|
-
|
|
Sep 17
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
6,000
-2.9%
|
-
|
|
Aug 18
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,081
-5.94%
|
$758,698
$58.15 P/Share
|
|
Aug 16
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.2%
|
-
|
|
Aug 06
2025
|
Douglas A Treco |
BUY
Open market or private purchase
|
Direct |
20,000
+47.62%
|
$1,140,000
$57.03 P/Share
|
|
Jul 16
2025
|
Simeon George |
BUY
Open market or private purchase
|
Indirect |
989,812
+17.6%
|
$51,470,224
$52.03 P/Share
|
|
May 29
2025
|
Naimish Patel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,932
-39.32%
|
$137,620
$35.94 P/Share
|
|
May 28
2025
|
Naimish Patel Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Mar 21
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
3,185
-3.75%
|
$130,585
$41.23 P/Share
|
|
Mar 21
2025
|
Raju Prasad Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,197
-11.59%
|
$90,077
$41.23 P/Share
|
|
Mar 21
2025
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,714
-13.98%
|
$70,274
$41.23 P/Share
|
|
Mar 21
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,031
-4.89%
|
$411,271
$41.23 P/Share
|
|
Mar 20
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+6.86%
|
-
|
|
Mar 20
2025
|
Raju Prasad Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+24.79%
|
-
|
|
Mar 20
2025
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+23.43%
|
-
|
|
Mar 20
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,688
+8.76%
|
-
|
|
Mar 17
2025
|
Raju Prasad Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,762
-22.83%
|
$154,242
$41.8 P/Share
|
|
Mar 14
2025
|
Raju Prasad Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.77%
|
-
|
|
Mar 12
2025
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
190
-2.18%
|
$8,170
$43.32 P/Share
|
|
Mar 12
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,116
-1.4%
|
$47,988
$43.32 P/Share
|
|
Mar 12
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,462
-2.35%
|
$191,866
$43.32 P/Share
|
|
Mar 11
2025
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
435
+4.76%
|
-
|
|
Mar 11
2025
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,198
-12.66%
|
$50,316
$42.42 P/Share
|
|
Mar 11
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+2.74%
|
-
|
|
Mar 11
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,850
-3.55%
|
$119,700
$42.42 P/Share
|
|
Mar 11
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+4.53%
|
-
|
|
Mar 11
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,973
-5.23%
|
$418,866
$42.42 P/Share
|
|
Mar 10
2025
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,399
+20.23%
|
-
|
|
Mar 10
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+6.4%
|
-
|
|
Mar 10
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,250
+9.16%
|
-
|
|
Feb 26
2025
|
John Greene |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$308,000
$44.85 P/Share
|
|
Feb 19
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,288
-6.59%
|
$1,365,552
$54.0 P/Share
|
|
Feb 19
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,947
-2.53%
|
$101,244
$52.8 P/Share
|
|
Feb 19
2025
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
333
-4.5%
|
$17,316
$52.8 P/Share
|
|
Feb 18
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+4.74%
|
-
|
|
Feb 18
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
9,595
-11.62%
|
$508,535
$53.85 P/Share
|
|
Feb 18
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,640
-5.58%
|
$640,200
$55.05 P/Share
|
|
Feb 18
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+5.97%
|
-
|
|
Feb 18
2025
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+8.08%
|
-
|
|
Feb 16
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.49%
|
-
|
|
Dec 24
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,751
+6.58%
|
$220,016
$16.21 P/Share
|
|
Dec 02
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.63%
|
$825,000
$55.1 P/Share
|
|
Nov 11
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-6.79%
|
$1,650,000
$55.85 P/Share
|
|
Oct 14
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,293
-1.86%
|
$197,478
$46.28 P/Share
|
|
Oct 14
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,089
-1.71%
|
$50,094
$46.28 P/Share
|